1-10 of 10
Holly Gundacker
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Response to High Dose Cytarabine (HIDAC) As First Salvage for Relapsed Acute Lymphocytic Leukemia in Patients Receiving HIDAC As Initial Therapy

Anjali S. Advani, MD, Holly Gundacker, Nolyn Nyatanga, MD, Paul Elson, Peter J. Rosen, MD, Jennifer Bates, BS, CCRP, Mikkael A. Sekeres, MD, MS, Matt Kalaycio, MD, Ronald Sobecks, MD, Edward Copelan, MD, Frederick R. Appelbaum, MD
Journal: Blood
Blood (2011) 118 (21): 2594.
https://doi.org/10.1182/blood.V118.21.2594.2594
Published: 2011
Journal Articles

Outcome and Prevalence of Hyperdiploidy and Hypodiploidy in Adults with Newly Diagnosed Acute Lymphocytic Leukemia: A SWOG Study

Anjali S. Advani, MD, Holly Gundacker, Marilyn L. Slovak, PhD, Karl S. Theil, MD, Stephen J. Forman, Jerald P. Radich, MD, Frederick R. Appelbaum, MD
Journal: Blood
Blood (2011) 118 (21): 2555.
https://doi.org/10.1182/blood.V118.21.2555.2555
Published: 2011
Journal Articles

A phase 2 study of lenalidomide monotherapy in patients with deletion 5q acute myeloid leukemia: Southwest Oncology Group Study S0605

Clinical Trials & Observations
Mikkael A. Sekeres, Holly Gundacker, Jeffrey Lancet, Anjali Advani, Stephen Petersdorf, Jane Liesveld, Deborah Mulford, Tom Norwood, Cheryl L. Willman, Frederick R. Appelbaum, Alan F. List
Journal: Blood
Blood (2011) 118 (3): 523–528.
https://doi.org/10.1182/blood-2011-02-337303
Published: 2011
Journal Articles

A Phase II Study of Lenalidomide for Previously Untreated Deletion (del) 5q Acute Myeloid Leukemia (AML) Patients Age 60 or Older Who Are Not Candidates for Remission Induction Chemotherapy (Southwest Oncology Group Study S0605)

Mikkael A. Sekeres, MD, MS, Holly Gundacker, Jeffrey Lancet, MD, Anjali Advani, MD, Stephen Petersdorf, Jane L. Liesveld, MD, Deborah Mulford, Tom Norwood, Cheryl L. Willman, MD, Alan F. List, Frederick R. Appelbaum, MD
Journal: Blood
Blood (2010) 116 (21): 332.
https://doi.org/10.1182/blood.V116.21.332.332
Published: 2010
Journal Articles

Analysis of CRLF2/JAK Expression and Mutation Status In Adult ALL Patients

Olga Sala Torra, Holly Gundacker, Galina Pogosov, Era Pogosova-Agadjanyan, Stephen J Forman, Margaret O'Donnell, M.D., F.R.C.P.C., Frederick R. Appelbaum, MD, Cheryl L. Willman, MD, Jerald P. Radich, MD
Journal: Blood
Blood (2010) 116 (21): 758.
https://doi.org/10.1182/blood.V116.21.758.758
Published: 2010
Journal Articles

Southwest Oncology Group Study S0530: A Phase 2 Trial of Clofarabine/ Cytarabine for Relapsed/ Refractory Acute Lymphocytic Leukemia.

Anjali Advani, MD, Holly Gundacker, MS, Olga Sala-Torra, MD, Jerald Radich, MD, Raymond Lai, MD, PhD, Marilyn L. Slovak, PhD, Jeffrey E Lancet, MD, Steve Coutre, MD, Robert K Stuart, MD, Martha P. Mims, MD, PhD, Patrick Stiff, MD, Frederick R. Appelbaum, MD
Journal: Blood
Blood (2009) 114 (22): 3094.
https://doi.org/10.1182/blood.V114.22.3094.3094
Published: 2009
Journal Articles

Gene expression profiling of adult acute myeloid leukemia identifies novel biologic clusters for risk classification and outcome prediction

Clinical Trials & Observations
Carla S. Wilson, George S. Davidson, Shawn B. Martin, Erik Andries, Jeffrey Potter, Richard Harvey, Kerem Ar, Yuexian Xu, Kenneth J. Kopecky, Donna P. Ankerst, Holly Gundacker, Marilyn L. Slovak, Monica Mosquera-Caro, I-Ming Chen, Derek L. Stirewalt, Maurice Murphy, Frederick A. Schultz, Huining Kang, Xuefei Wang, Jerald P. Radich, Frederick R. Appelbaum, Susan R. Atlas, John Godwin, Cheryl L. Willman
Journal: Blood
Blood (2006) 108 (2): 685–696.
https://doi.org/10.1182/blood-2004-12-4633
Published: 2006
Includes: Supplemental data
Journal Articles

Age and acute myeloid leukemia

Clinical Trials & Observations
Frederick R. Appelbaum, Holly Gundacker, David R. Head, Marilyn L. Slovak, Cheryl L. Willman, John E. Godwin, Jeanne E. Anderson, Stephen H. Petersdorf
Journal: Blood
Blood (2006) 107 (9): 3481–3485.
https://doi.org/10.1182/blood-2005-09-3724
Published: 2006
Journal Articles

Acute Myeloid Leukemia (AML) with t(6;9)(p23;q34) Defines a Very Poor Risk Leukemia Subgroup with Distinguishing Clinicopathological Features: A United States (US) Cytogenetics Intergroup Study of 62 AML and MDS Cases.

Marilyn L. Slovak, Clara D. Bloomfield, Holly Gundacker, Gordon Dewald, Frederick R. Appelbaum, Richard A. Larson, Martin S. Tallman, Cheryl Willman, Yaddanapudi Ravindranath, Todd A. Alonzo, Andrew Carroll, Betsy Hirsch, Susana Raimondi, Nyla A. Heerema
Journal: Blood
Blood (2004) 104 (11): 567.
https://doi.org/10.1182/blood.V104.11.567.567
Published: 2004
Journal Articles

Impact of trisomy 8 (+8) on clinical presentation, treatment response, and survival in acute myeloid leukemia: a Southwest Oncology Group study

Clinical Trials & Observations
Sandra R. Wolman, Holly Gundacker, Frederick R. Appelbaum, Marilyn L. Slovak
Journal: Blood
Blood (2002) 100 (1): 29–35.
https://doi.org/10.1182/blood.V100.1.29
Published: 2002